Видео ютуба по тегу Latest Amgn News

Amgen CEO: There are a bunch of ways to win for patients when it comes to weight loss
Amgen CEO: There are a bunch of ways to win for patients when it comes to weight loss
Amgen CEO talks trial results of cardiac drug Repatha
Amgen CEO talks trial results of cardiac drug Repatha
AMGEN INC STOCK LATEST NEWS 6NOV'25/AMGEN INC STOCK WITH NEW TARGETS FORCAST
AMGEN INC STOCK LATEST NEWS 6NOV'25/AMGEN INC STOCK WITH NEW TARGETS FORCAST
Cramer's Stop Trading: Amgen
Cramer's Stop Trading: Amgen
Amgen CEO announces $1 billion in new investments
Amgen CEO announces $1 billion in new investments
Amgen to buy Horizon Therapeutics for $116.50 per share
Amgen to buy Horizon Therapeutics for $116.50 per share
Amgen Said to Agree to $26 Billion Purchase of Horizon
Amgen Said to Agree to $26 Billion Purchase of Horizon
Amgen beats on Q2 revenue, slightly raises guidance
Amgen beats on Q2 revenue, slightly raises guidance
Amgen Prostate Cancer Data May Boost Sales $2 Billion
Amgen Prostate Cancer Data May Boost Sales $2 Billion
Amgen shares fall on anti-obesity drug | REUTERS
Amgen shares fall on anti-obesity drug | REUTERS
Amgen shares sink despite quarterly beat, FDA places obesity drug on clinical hold
Amgen shares sink despite quarterly beat, FDA places obesity drug on clinical hold
Amgen has 'a lot to prove' in the weight-loss drug category, says Mizuho's Jared Holz
Amgen has 'a lot to prove' in the weight-loss drug category, says Mizuho's Jared Holz
Addressing worldwide challenges in cardiovascular disease care #amgen #cardiovasculardisease
Addressing worldwide challenges in cardiovascular disease care #amgen #cardiovasculardisease
Cramer's Stop Trading: Amgen
Cramer's Stop Trading: Amgen
Trade Tracker: Bill Baruch buys more Amgen
Trade Tracker: Bill Baruch buys more Amgen
Amgen Shares Plunge After Weight-Loss Drug Misses Expectations | News Today | DRM News | AF14
Amgen Shares Plunge After Weight-Loss Drug Misses Expectations | News Today | DRM News | AF14
Get an Asthma Action Plan #amgen #severeasthma #patient
Get an Asthma Action Plan #amgen #severeasthma #patient
Amgen CEO Bradway on Vaccine Rollout, New Products
Amgen CEO Bradway on Vaccine Rollout, New Products
Gilead beats EPS expectations by $0.10; Amgen raises low end of full-year revenue outlook
Gilead beats EPS expectations by $0.10; Amgen raises low end of full-year revenue outlook
News Update: Former Novartis AG CFO Heads to Amgen, Inc. (NVS,AMGN)
News Update: Former Novartis AG CFO Heads to Amgen, Inc. (NVS,AMGN)